0.000USD0.000åå ŽååŒÂ 07/27, 09:30 (ET)
11.16BæäŸ¡ç·é¡
101.45çŽè¿12ã¶æPER
äž»èŠããŒã¿
71.900å§å€
71.940é«å€
2.07Måºæ¥é«
101.45çŽè¿12ã¶æPER
34.44äºæ³PER
0.320çŽè¿12ã¶æé
åœ
1.33%売買å転ç
71.770忥çµå€
71.580å®å€
106.25M売買代é
152.01æ ªäŸ¡åçç
5.67PBRïŒæ ªäŸ¡çŽè³ç£åçïŒ
0.45%çŽè¿12ã¶æé
åœå©åã
4.22%ç·è³ç£å©çç
72.16052é±é«å€
0.73åºæ¥é«æ¯ç%
73.36MçŽå©ç
155.75Mæ ªåŒæ°
0.70571æ ªåœããå©çïŒEPSïŒ
1.37ããŒã¿å€
5.34%èªå·±è³æ¬å©çç
43.19552é±å®å€
0.50%æ¯ãå¹
67.25%ç²å©çç
11.16BæäŸ¡ç·é¡
0.41ãªã¹ã¯ãªã¿ãŒã³
2.66%ãªã¹ã¯ç
é貚: USD æŽæ°æå»: 2026-07-24 äž»èŠã€ã³ãµã€ã
Bio-Techne Corpã®ãã¡ã³ãã¡ã³ã¿ã«ãºã¯æ¯èŒçéåžžã«å¥å
šã§ããæé·ã®å¯èœæ§ã¯é«ãã§ããããªã¥ãšãŒã·ã§ã³ã¯é©æ£äŸ¡æ Œãšè©äŸ¡ãããŠããŸãããã€ãªãã¯ãããžãŒ & å»çç ç©¶æ¥çã§ã®é äœã¯386äž36äœã§ããæ©é¢æè³å®¶ä¿æçã¯éåžžã«é«ãã§ããéå»1ãæéã«è€æ°ã®ã¢ããªã¹ããããŒã«ããšè©äŸ¡ããæé«ç®æšæ ªäŸ¡ã¯70.30ãšãããŠããŸããäžæçã«ã¯ãæ ªäŸ¡ã¯äžæãã¬ã³ããšäºæ³ãããŸããéå»1ãæã®æ ªåŒåžå Žã®ããã©ãŒãã³ã¹ã¯å¹³åçã§ããããå瀟ã®ãã¡ã³ãã¡ã³ã¿ã«ãºã¯å
調ã§ããæ ªäŸ¡ã¯æ¯æç·ã𿵿ç·ã®éã§æšªã°ãæšç§»ããŠãããã¬ã³ãžçžå Žã§ã®ã¹ã€ã³ã°ãã¬ãŒãã«é©ããŠããŸãã
Bio-Techne Corpã®ã¹ã³ã¢î°î°
ãµããŒãã©ã€ã³ãšã¬ãžã¹ã¿ã³ã¹ã©ã€ã³

äŒç€Ÿããé¢é£ããŒã¿ããŸã é瀺ãããŠããŸããã
éåžžã«äœã
éåžžã«é«ã
Bio-Techne Corpã®æ³šç®ãã€ã³ã
匷ã¿ãªã¹ã¯
Bio-Techne Corp ãã¥ãŒã¹
åçäºæž¬î
匷åè²·ã
è²·ã
äžç«
売ã
匷å売ã
Ionis Pharmaceuticals Inc
IONS
27
ææšî
ææš
売ã(2)
äžç«(2)
è²·ã(2)
ç§»åå¹³å
売ã(2)
äžç«(0)
è²·ã(4)
è²¡åææšî
EPS

äŒç€Ÿããé¢é£ããŒã¿ããŸã é瀺ãããŠããŸããã
ç·å£²äžé«

äŒç€Ÿããé¢é£ããŒã¿ããŸã é瀺ãããŠããŸããã
Bio-Techne Corpã®äŒæ¥æ
å ±î
Bio-Techne Corporation develop, manufacture and sell life science reagents, instruments and services for the research, diagnostics and bioprocessing markets worldwide. The Companyâs segments include Protein Sciences segment and Diagnostics and Spatial Biology segment. The Protein Sciences segment is a developer and manufacturer of biological reagents used in all aspects of life science research, diagnostics and cell and gene therapy. The Diagnostics and Spatial Biology segment develops and manufactures diagnostic products, including controls, calibrators, and diagnostic assays for the regulated diagnostics market, advanced tissue-based in-situ hybridization assays and instrumentation for spatial genomic and tissue biopsy analysis and genetic and oncology kits for research and clinical applications. Its product portfolio and application enable scientific investigations into biological processes and molecular diagnostics and progression of specific diseases.
äŒæ¥ã³ãŒãTECH
äŒæ¥åBio-Techne Corp
æé«çµå¶è²¬ä»»è
ãCEOãKelderman (Kim)
ãŠã§ããµã€ãhttps://www.bio-techne.com/
æ ªäž»çµ±èšî
ãããã質å
Bio-Techne CorpïŒTECHïŒã®çŸåšã®æ ªäŸ¡ã¯ãããã§ããïŒ
îBio-Techne CorpïŒTECHïŒã®çŸåšã®æ ªäŸ¡ã¯71.60ã§ãã
Bio-Techne Corpã®ãã£ãã«ãŒã·ã³ãã«ã¯äœã§ããïŒ
îBio-Techne Corpã®ãã£ãã«ãŒã·ã³ãã«ã¯TECHã§ãã
Bio-Techne Corpã®52é±é«å€ã¯ãããã§ããïŒ
îBio-Techne Corpã®52é±é«å€ã¯72.16ã§ãã
Bio-Techne Corpã®52é±å®å€ã¯ãããã§ããïŒ
îBio-Techne Corpã®52é±å®å€ã¯43.20ã§ãã
Bio-Techne Corpã®æäŸ¡ç·é¡ã¯ãããã§ããïŒ
îBio-Techne Corpã®æäŸ¡ç·é¡ã¯11.16Bã§ãã
Bio-Techne Corp (TECH) ã®çŸåšã®è©äŸ¡ã¯ãè²·ããããããŒã«ãããã売ããã®ã©ãã§ããïŒ
îã¢ããªã¹ãã«ãããšãBio-Techne CorpïŒTECHïŒã®ç·åè©äŸ¡ã¯signal_holdã§ãç®æšæ ªäŸ¡ã¯70.30ã§ãã
Bio-Techne Corp (TECH) ã®1æ ªåœããå©çïŒEPS TTMïŒã¯ãããã§ããïŒ
îBio-Techne CorpïŒTECHïŒã®1æ ªåœããå©çïŒEPS TTMïŒã¯0.47ã§ãã